IMPLANT SITE HYPERTROPHY

IMPLANT SITE HYPERTROPHY was reported 9 times

These drug classes are most commonly taken by patients reporting IMPLANT SITE HYPERTROPHY:

# Drug Count
0 Progestin [EPC] 3
1 Calcineurin Inhibitor Immunosuppressant [EPC] 1
2 HMG-CoA Reductase Inhibitor [EPC] 1
3 Polyene Antifungal [EPC] 1